Synthesis and Antimalarial Activity of New Enantiopure Aminoalcoholpyrrolo[ 1,2-a]quinoxalines

By  

Medicinal Chemistry, Vol. 14, Iss. 3, 2018-04 ,pp. : 293-303

Bentham Science Publishers

Access to resources Recommend Favorite

Imidazo[1,2-a]quinoxalines: synthesis and cyclic nucleotide phosphodiesterase inhibitory activity

By Parra S.   Laurent F.   Subra G.   Deleuze-Masquefa C.   Benezech V.   Fabreguettes J.-R.   Vidal J.-P.   Pocock T.   Elliott K.   Small R.   Escale R.   Michel A.   Chapat J.-P.   Bonnet P.-A.  

European Journal of Medicinal Chemistry, Vol. 36, Iss. 3, 2001-03 ,pp. : 255-264

Elsevier

Access to resources Recommend Favorite

Non-Peptide Vasopressin V1b Receptor Antagonists as Potential Drugs for the Treatment of Stress-Related Disorders

By  

Current Pharmaceutical Design, Vol. 11, Iss. 12, 2005-05 ,pp. : 1549-1559

Bentham Science Publishers

Access to resources Recommend Favorite

Quinoxaline chemistry. Part 16. 4-Substituted anilino and 4-substituted phenoxymethyl pyrrolo[1,2-a]quinoxalines and N-[4-(pyrrolo[1,2-a]quinoxalin-4-yl)amino and hydroxymethyl]benzoyl glutamates. Synthesis and evaluation of in vitro biological activity

By Alleca S.   Corona P.   Loriga M.   Paglietti G.   Loddo R.   Mascia V.   Busonera B.   La Colla P.  

Il Farmaco, Vol. 58, Iss. 9, 2003-09 ,pp. : 639-650

Elsevier

Access to resources Recommend Favorite

A novel template for non-peptide CCR5 receptor antagonists

By  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 4, 2001-04 ,pp. : 697-700

Informa Healthcare

Access to resources Recommend Favorite